Extendicare Net Debt / EBITDA
The Net Debt to EBITDA of Extendicare (EXE.TO) as of Oct 6, 2026 is -0.11. In the previous year, Net Debt to EBITDA was 1.06 — a change of -110.17% (lower).
Get this data via API
Financial Data API
Net Debt / EBITDA
-0.11
YoY
-110.17%
Last updated:
The Extendicare Net Debt / EBITDA history
3 Years
10 Years
25 Years
Max
| YEAR | Net Debt / EBITDA | YoY |
|---|---|---|
| -0.11 | -110.17% | |
| 1.06 | -60.81% | |
| 2.72 | -34.12% | |
| 4.12 | -23.16% | |
| 5.37 | +84.31% | |
| 2.91 | -41.80% | |
| 5.00 | -19.97% | |
| 6.25 | +49.61% | |
| 4.18 | -7.54% | |
| 4.52 | +38.50% | |
| 3.26 | -46.64% | |
| 6.12 | -71.16% | |
| 21.21 | +127.78% | |
| 9.31 | -46.18% | |
| 17.30 | +199.09% | |
| 5.78 | +17.04% | |
| 4.94 | -34.72% | |
| 7.57 | +20.51% | |
| 6.28 | +12.06% | |
| 5.61 | — |
Extendicare Stock analysis
Frequently Asked Questions about Extendicare stock
Net Debt to EBITDA of Extendicare is -0.11 in 2026.
Net Debt to EBITDA of Extendicare changed from 1.06 to -0.11, representing a -110.17% change. The value is lower than the previous year.
On Eulerpool you can find the complete historical development of Net Debt to EBITDA Extendicare since 2006 – with annual values, charts, and detailed analysis.
Net Debt/EBITDA measures how many years it would take to repay all debt using EBITDA. Lower ratios indicate stronger debt repayment capacity.
A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Debt to EBITDA's Extendicare with sector peers and the industry average to assess whether it is attractive.
Leverage — Extendicare
All Key Metrics — Extendicare
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth